Am J Perinatol 2021; 38(10): 983-992
DOI: 10.1055/s-0041-1728835
SMFM Fellowship Series Article

Improving the Timely Delivery of Antihypertensive Medication for Severe Perinatal Hypertension in Pregnancy and Postpartum

Patrick Schneider*
1   Department of Obstetrics and Gynecology, Pritzker School of Medicine, Evanston Hospital, NorthShore University HealthSystem/University of Chicago, Evanston, Illinois
,
Patricia Ann Lee King
2   Feinberg School of Medicine, Center for HealthCare Studies, Northwestern University, Chicago, Illinois
,
Lauren Keenan-Devlin
3   Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, Illinois
,
Ann E.B. Borders
1   Department of Obstetrics and Gynecology, Pritzker School of Medicine, Evanston Hospital, NorthShore University HealthSystem/University of Chicago, Evanston, Illinois
› Author Affiliations

Abstract

Objective Sustained blood pressures ≥160/110 during pregnancy and the postpartum period require timely antihypertensive therapy. Hospital-level experiences outlining the efforts to improve timely delivery of care within 60 minutes have not been described. The objective of this analysis was to assess changes in care practices of an inpatient obstetrical health care team following the implementation of a quality improvement initiative for severe perinatal hypertension during pregnancy and the postpartum period.

Study Design In January 2016, NorthShore University HealthSystem Evanston Hospital launched a quality improvement initiative focusing on perinatal hypertension, as part of a larger, statewide quality initiative via the Illinois Perinatal Quality Collaborative. We performed a retrospective cohort study of all pregnant and postpartum patients with sustained severely elevated blood pressure (two severely elevated blood pressures ≤15 minutes apart) with baseline data from 2015 and data collected during the project from 2016 through 2017. Changes in clinical practice and outcomes were compared before and after the start of the project. Statistical process control charts were used to demonstrate process-behavior changes over time.

Results Comparing the baseline to the last quarter of 2017, there was a significant increase in the administration of medication within 60 minutes for severe perinatal hypertension (p <0.001). Implementation of a protocol for event-specific debriefing for each severe perinatal hypertension episode was associated with increased odds of the care team administering medication within 60 minutes of the diagnosis of severe perinatal hypertension (adjusted odds ratio 3.20, 95% confidence interval 1.73–5.91, p < 0.01).

Conclusion Implementation of a quality improvement initiative for perinatal hypertension associated with pregnancy and postpartum improved the delivery of appropriate and timely therapy for severely elevated blood pressures and demonstrated the impact of interdisciplinary communication in the process.

Key Points

  • Process of hospital-level implementation of a state quality improvement initiative.

  • Evidence of improvement in care delivery for severe perinatal hypertension (HTN).

  • Episode related debriefing by the clinical team improved perinatal HTN care.

* Present address: The Ohio State University Wexner Medical Center, Department of Obstetrics and Gynecology, 395 W 12th Avenue, 5th Fl, Columbus, OH 43210.


Supplementary Material



Publication History

Received: 30 June 2020

Accepted: 02 March 2021

Article published online:
02 May 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Kilpatrick SJ, Abreo A, Greene N. et al. Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension. Am J Obstet Gynecol 2016; 215 (01) 91.e1-91.e7
  • 2 Arora KS, Shields LE, Grobman WA, D'Alton ME, Lappen JR, Mercer BM. Triggers, bundles, protocols, and checklists—what every maternal care provider needs to know. Am J Obstet Gynecol 2016; 214 (04) 444-451
  • 3 Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol 2015; 125 (01) 5-12
  • 4 Fingar KR, (IBM Watson Health), Mabry-Hernandez I, Ngo-Metzger Q, Wolff T, (AHRQ), Steiner CA, (Institute for Health Research, Kaiser Permanente), Elixhauser A. (AHRQ). Delivery Hospitalizations Involving Preeclampsia and Eclampsia, 2005–2014. HCUP Statistical Brief#222 April 2017. Agency for Healthcare Research and Quality, Rockville, MD. Accessed April 21, 2021 at www.hcup-us.ahrq.gov/reports/statbriefs/sb222-Preeclampsia-Eclampsia-Delivery-Trends.pdf
  • 5 ACOG Committee Opinion No. ACOG Committee Opinion No. 767 summary: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2019; 133 (02) 409-412
  • 6 Main EK, McCain CL, Morton CH, Holtby S, Lawton ES. Pregnancy-related mortality in California: causes, characteristics, and improvement opportunities. Obstet Gynecol 2015; 125 (04) 938-947
  • 7 Ozimek JA, Eddins RM, Greene N. et al. Opportunities for improvement in care among women with severe maternal morbidity. Am J Obstet Gynecol 2016; 215 (04) 509.e1-509.e6
  • 8 Menzies J, Magee LA, Li J. et al; Preeclampsia Integrated Estimate of RiSk (PIERS) Study Group. Instituting surveillance guidelines and adverse outcomes in preeclampsia. Obstet Gynecol 2007; 110 (01) 121-127
  • 9 von Dadelszen P, Sawchuck D, McMaster R. et al; Translating Evidence-Based Surveillance and Treatment Strategies (TESS) Group. The active implementation of pregnancy hypertension guidelines in British Columbia. Obstet Gynecol 2010; 116 (03) 659-666
  • 10 ACOG Practice Bulletin No. 222: gestational hypertension and preeclampsia. Obstet Gynecol 2020; 135 (06) e237-e260
  • 11 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy. Obstet Gynecol 2019; 133 (01) e26-e50
  • 12 Center for Disease Control and Prevention's Division of Reproductive Health Perinatal Quality Collaborative Guide Working Group. State Perinatal Quality Collaboratives. Accessed April 30, 2018 at: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pqc-states.html
  • 13 Shields LE, Wiesner S, Klein C, Pelletreau B, Hedriana HL. Early standardized treatment of critical blood pressure elevations is associated with a reduction in eclampsia and severe maternal morbidity. Am J Obstet Gynecol 2017; 216 (04) 415.e1-415.e5
  • 14 Hypertension in Pregnancy (HIP). Florida Perinatal Quality Collaborative. Accessed May 5, 2018 at: https://health.usf.edu/publichealth/chiles/fpqc/hip
  • 15 Druzin ML, Shields LE, Peterson NL, Cape V. Preeclampsia toolkit: improving health care response to preeclampsia (California Maternal Quality Care Collaborative Toolkit to Transform Maternity Care) developed under contract #11-10006 with the California Department of Public Health; Maternal, Child and Adolescent Health Division; Published by the California Maternal Quality Care Collaborative, November 2013
  • 16 Conservative Management of Preeclampsia. Perinatal Quality Collaborative of North Carolina. Accessed May 5, 2018 at: https://www.pqcnc.org/node/13431
  • 17 Louis JM. Promise and challenges of maternal health collaboratives. Clin Obstet Gynecol 2015; 58 (02) 362-369
  • 18 Gould JB. The role of regional collaboratives: the California Perinatal Quality Care Collaborative model. Clin Perinatol 2010; 37 (01) 71-86
  • 19 Akula VP, Gould JB, Kan P, Bollman L, Profit J, Lee HC. Characteristics of neonatal transports in California. J Perinatol 2016; 36 (12) 1122-1127
  • 20 Main EK, Abreo A, McNulty J. et al. Measuring severe maternal morbidity: validation of potential measures. Am J Obstet Gynecol 2016; 214 (05) 643.e1-643.e10
  • 21 Illinois Perinatal Quality Collaborative. Initiatives: maternal hypertension. Accessed April 30, 2018 at: https://ilpqc.org/severe-maternal-hypertension
  • 22 Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol 2012; 120 (05) 1029-1036
  • 23 Benneyan JC, Lloyd RC, Plsek PE. Statistical process control as a tool for research and healthcare improvement. Qual Saf Health Care 2003; 12 (06) 458-464
  • 24 Wagner B, Meirowitz N, Shah J. et al. Comprehensive perinatal safety initiative to reduce adverse obstetric events. J Healthc Qual 2012; 34 (01) 6-15
  • 25 Burgansky A, Montalto D, Siddiqui NA. The safe motherhood initiative: the development and implementation of standardized obstetric care bundles in New York. Semin Perinatol 2016; 40 (02) 124-131
  • 26 Zuckerwise LC, Hustedt MM, Lipkind HS, Funai EF, Raab CA, Pettker CM. Effect of implementing a standardized shoulder dystocia documentation form on quality of delivery notes. J Patient Saf 2020; 16 (04) 259-263
  • 27 Grobman WA, Miller D, Burke C, Hornbogen A, Tam K, Costello R. Outcomes associated with introduction of a shoulder dystocia protocol. Am J Obstet Gynecol 2011; 205 (06) 513-517
  • 28 Gupta M, Kaplan HC. Using statistical process control to drive improvement in neonatal care: a practical introduction to control charts. Clin Perinatol 2017; 44 (03) 627-644
  • 29 Koetsier A, van der Veer SN, Jager KJ, Peek N, de Keizer NF. Control charts in healthcare quality improvement. A systematic review on adherence to methodological criteria. Methods Inf Med 2012; 51 (03) 189-198
  • 30 Lee King P, Keenan-Devlin L, Gordon C, Goel S, Borders A. Reducing time to treatment for severe maternal hypertension through statewide quality improvement. Am J Obstet Gynecol 2018; 218 (01) S4
  • 31 Gupta M, Donovan EF, Henderson Z. State-based perinatal quality collaboratives: pursuing improvements in perinatal health outcomes for all mothers and newborns. Semin Perinatol 2017; 41 (03) 195-203